Evaluation of inhaled nitric oxide (iNO) treatment for moderate-to-severe ARDS in critically ill patients with COVID-19: a multicenter cohort study
Al Sulaiman$n$ et al., Critical Care, doi:10.1186/s13054-022-04158-y
https://c19early.org/alsulaiman4.html